Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTIVE: Infliximab + Azathioprine vs Steroids + Azathioprine in ASUC
NCT02425852Phase 4Completed
- Sponsor
- GETAID
- Start
- Dec 2016
- Primary completion
- Jun 2022
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of infliximab in ulcerative colitis (UC), sponsored by GETAID. Started Dec 2016; status: completed.
02
Drugs
infliximab
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT02425852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02425852.